iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: http://pubmed.ncbi.nlm.nih.gov/39064140/
Charting Alzheimer's Disease and Dementia: Epidemiological Insights, Risk Factors and Prevention Pathways - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jul 13;13(14):4100.
doi: 10.3390/jcm13144100.

Charting Alzheimer's Disease and Dementia: Epidemiological Insights, Risk Factors and Prevention Pathways

Israel Contador  1   2 , Bárbara Buch-Vicente  1 , Teodoro Del Ser  3 , Sara Llamas-Velasco  4   5 , Alberto Villarejo-Galende  4   5 , Julián Benito-León  4   5   6   7 , Félix Bermejo-Pareja  6   7
Affiliations
Review

Charting Alzheimer's Disease and Dementia: Epidemiological Insights, Risk Factors and Prevention Pathways

Israel Contador et al. J Clin Med. .

Abstract

Alzheimer's disease (AD), the most common cause of dementia, is a complex and multifactorial condition without cure at present. The latest treatments, based on anti-amyloid monoclonal antibodies, have only a modest effect in reducing the progression of cognitive decline in AD, whereas the possibility of preventing AD has become a crucial area of research. In fact, recent studies have observed a decrease in dementia incidence in developed regions such as the US and Europe. However, these trends have not been mirrored in non-Western countries (Japan or China), and the contributing factors of this reduction remain unclear. The Lancet Commission has delineated a constrained classification of 12 risk factors across different life stages. Nevertheless, the scientific literature has pointed to over 200 factors-including sociodemographic, medical, psychological, and sociocultural conditions-related to the development of dementia/AD. This narrative review aims to synthesize the risk/protective factors of dementia/AD. Essentially, we found that risk/protective factors vary between individuals and populations, complicating the creation of a unified prevention strategy. Moreover, dementia/AD explanatory mechanisms involve a diverse array of genetic and environmental factors that interact from the early stages of life. In the future, studies across different population-based cohorts are essential to validate risk/protective factors of dementia. This evidence would help develop public health policies to decrease the incidence of dementia.

Keywords: Alzheimer’s disease; epidemiology; prevention; public health; risk factors.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Dementia pathways and main modifiable risk factors across lifespan. The familial dementia category represents a minimal percentage of cases directly explained by autosomal gene mutations. In contrast, modifiable factors may exert their effects on different biological systems of the organism (genes, immunological response, and brain connectivity) at different lifespan periods, raising the likelihood of sporadic dementia/AD. In addition to their weighted specific effects, risk factors may interact in a synergistic and complex way with different lifestyle habits (e.g., diet, sleep), population factors (e.g., air pollution, health system), or unknown conditions converging at late life (represented by the dotted area). Modifiable risk factors may interact with genes (epigenetic pathway is shown in yellow), boosting the probability of AD/dementia compared to those sporadic cases without these traits (green line). It should be noted that dementia onset can vary significantly between individuals at different paths, but it is represented in a simplified visual manner for the readers (see red dotted area).
Figure 2
Figure 2
Coping against dementia: resilience and resistance mechanisms. The term resistance implies slower or delaying the onset of AD-associated neuropathology represented by blue color. However, resilience refers to the brain’s capacity to maintain cognitive and functional performance against pathology, with cognitive reserve being the most known form. Thus, people with higher CR (brown line) may show better performance than those with lower CR when facing similar levels of pathology.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

  • Dementia and Cognitive Decline: A HEALM Approach.
    Jaqua EE, Tran MN, Alvarez P, Gupta M, Yoong J. Jaqua EE, et al. Am J Lifestyle Med. 2024 Oct 9:15598276241291508. doi: 10.1177/15598276241291508. Online ahead of print. Am J Lifestyle Med. 2024. PMID: 39540186 Free PMC article. Review.

References

    1. Wimo A., Seeher K., Cataldi R., Cyhlarova E., Dielemann J.L., Frisell O., Guerchet M., Jönsson L., Malaha A.K., Nichols E., et al. The Worldwide Costs of Dementia in 2019. Alzheimers Dement. 2023;19:2865–2873. doi: 10.1002/alz.12901. - DOI - PMC - PubMed
    1. Gustavsson A., Norton N., Fast T., Frölich L., Georges J., Holzapfel D., Kirabali T., Krolak-Salmon P., Rossini P.M., Ferretti M.T., et al. Global Estimates on the Number of Persons across the Alzheimer’s Disease Continuum. Alzheimers Dement. 2023;19:658–670. doi: 10.1002/alz.12694. - DOI - PubMed
    1. Satizabal C.L., Beiser A.S., Chouraki V., Chêne G., Dufouil C., Seshadri S. Incidence of Dementia over Three Decades in the Framingham Heart Study. N. Engl. J. Med. 2016;374:523–532. doi: 10.1056/NEJMoa1504327. - DOI - PMC - PubMed
    1. World Health Organization . Global Action Plan on the Public Health Response to Dementia 2017–2025. World Health Organization; Geneva, Switzerland: 2017.
    1. World Health Organization . Risk Reduction of Cognitive Decline and Dementia: WHO Guidelines. World Health Organization; Geneva, Switzerland: 2019. - PubMed

Grants and funding

Israel Contador was supported by the Ministry of Universities through the Salvador Madariaga Program for Senior Researchers (PRX22/00313).

LinkOut - more resources